Prevention of Systemic Infections Caused by Group B Streptococcus and Staphylococcus aureus by Multivalent Polysaccharide‐Protein Conjugate Vaccines
- 1 May 1995
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 754 (1) , 68-81
- https://doi.org/10.1111/j.1749-6632.1995.tb44439.x
Abstract
No abstract availableThis publication has 72 references indexed in Scilit:
- Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milkEuropean Journal of Pediatrics, 1992
- Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.Journal of Clinical Investigation, 1990
- Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B StreptococcusNew England Journal of Medicine, 1988
- Long-term sequelae of group B streptococcal meningitis in infantsThe Journal of Pediatrics, 1985
- Quantitation of IgG antibody to the type-specific polysaccharide of group B streptococcus type 1b in pregnant women and infected infantsThe Journal of Pediatrics, 1984
- Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureusDiagnostic Microbiology and Infectious Disease, 1984
- Estimation of the Protective Level of Human IgG Antibody to the Type-Specific Polysaccharide of Group B Streptococcus Type IaThe Journal of Infectious Diseases, 1983
- Quantitative Determination in Human Sera of Vaccine-Induced Antibody to Type-Specific Polysaccharides of Group B Streptococci Using an Enzyme-Linked Immunosorbent AssayThe Journal of Infectious Diseases, 1983
- Mouse Protection Test for Group B Streptococcus Type IIIThe Journal of Infectious Diseases, 1979
- Immunogenicity of polysaccharides from type III, group B Streptococcus.Journal of Clinical Investigation, 1978